An important piece from the inaugural Chief Health Equity Officer at Humana, Nwando Olayiwola, M. D., on the need for health
read full article ›May is #MentalHealthMonth Great piece in New York Times highlighting the expanding role that retail pharmacy providers will play in providing
read full article ›The pharmaceutical industry faces a large and ugly problem: the growing economic burden on their payer customers of specialty drugs.
read full article ›Oncology has largely been immune to the reimbursement pressures that challenge virtually every other drug category. But that’s changing, and
read full article ›Manufacturers think CMS bars them from helping Medicare patients afford their medicines. This is incorrect. There are solutions...
read full article ›Diversity is now rightly a corporate priority in America. Companies large and small know that improving their diversity and inclusion policies will improve their culture and workforce. And Pharma is no different. Pharmas want more diverse representation in management, their boards, and in clinical trials. Should a similar lens be applied to access and reimbursement challenges – and in particular to patient support programs?
read full article ›This past year presented so many different challenges and obstacles that tested our strength and resiliency. The global pandemic forced
read full article ›Here we go again… on May 3rd Cvshealth released the CVS Caremark 2020 Drug Trend Report. One eye-catching stat was the
read full article ›The FDA’s accelerated approval process drives tremendous upside benefits for manufactures and patients through delivery of therapeutic innovations earlier than
read full article ›